Skip to main content

Cells for Cells

is an international regenerative medicine company reducing cost and geographical barriers to accessing advanced therapeutic products

 

Since 2010

Cells for Cells has developed a diverse biotech portfolio of innovations tackling high-prevalence chronic diseases and the industry’s gaps

 

We are leaders

in the field of regenerative medicine in our region, with more than 800 patients who have been treated with our advanced therapies

 

Our outstanding

number of patent filings continues to grow as we discover and develop new biomedical products that can be out-licensed or become profitable spin-offs

1
1

Cells for Cells in numbers

800

Patients treated

18

Family patents

9

Clinical trials

120

Publications

13

Disclosed technologies

Experts in Cell Therapy and Regenerative Medicine

We develop life-changing therapies and implants for unresolved chronic diseases and tackle the growing challenges of the biomedical industry through visionary life science tools.

Tissue Engineering & Biomaterials

Advanced implants produced by combining smart biomaterials with tissue engineering techniques and cells.

See More

Cell and Exosome Therapy

Therapeutic products from the fittest allogeneic Mesenchymal Stem Cells and their extracellular vesicles.

See More

Life Science Tools

Devices and reagents with faster routes to commercialization and presented for
out-licensing.

See More

Our impact, highlighted by major media outlets